(18)F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Whi W, Lee H, Hong JY, Kang W, et al. Anticancer Res 2025;45:1273-1280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Whi W, Lee H, Hong JY, Kang W, et al. (18)F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Res 2025;45:1273-1280.
PMID: 40037882